Evidence map›Paper›PMID 30848072›Full record

ArticleAging cell2019

The p53/miRNAs/Ccna2 pathway serves as a novel regulator of cellular senescence: Complement of the canonical p53/p21 pathway.

Shun Xu, Weijia Wu, Haijiao Huang, Ruxiao Huang, Luoyijun Xie, Ailing Su, Shuang Liu, Ruinian Zheng, Yuan Yuan, Hui-Ling Zheng and 3 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Biochemical Targets and Molecular Mechanism of Matrine against Aging.International journal of molecular sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Shun XuInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Weijia WuInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Haijiao HuangInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Ruxiao HuangInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Luoyijun XieInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Ailing SuInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Shuang LiuInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Ruinian ZhengDepartment of Oncology, Dongguan People's Hospital, Dongguan, China.
Yuan YuanInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Hui-Ling ZhengInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Xuerong SunInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Xing-Dong XiongInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Xinguang LiuInstitute of Aging Research, Guangdong Medical University, Dongguan, China.
Guangdong Medical College · CNDongguan People’s Hospital · CN

Funding

"Climbing" Program of Guangdong Province pdjh2016b0219"Climbing" Program of Guangdong Province pdjhb0223Dongguan International Science & Technology Cooperation 201650812001Innovation Team Construction Projects in Ordinary University of Guangdong Province 2015KCXTD022National Natural Science Foundation of China 31600976National Natural Science Foundation of China 81170327National Natural Science Foundation of China 81671399Natural Science Foundation of Guangdong Province 2016A030313684Natural Science Foundation of Guangdong Province 9252402301000002Science & Technology Innovation Fund of Guangdong Medical University STIF201102Unique Innovative Projects in Ordinary University of Guangdong Province 2015KTSCX049
6 · The paper itself

Abstract

Aging is a multifactorial process characterized by the progressive deterioration of physiological functions. Among the multiple molecular mechanisms, microRNAs (miRNAs) have increasingly been implicated in the regulation of Aging process. However, the contribution of miRNAs to physiological Aging and the underlying mechanisms remain elusive. We herein performed high-throughput analysis using miRNA and mRNA microarray in the physiological Aging mouse, attempted to deepen into the understanding of the effects of miRNAs on Aging process at the "network" level. The data showed that various p53 responsive miRNAs, including miR-124, miR-34a and miR-29a/b/c, were up-regulated in Aging mouse compared with that in Young mouse. Further investigation unraveled that similar as miR-34a and miR-29, miR-124 significantly promoted cellular senescence. As expected, mRNA microarray and gene co-expression network analysis unveiled that the most down-regulated mRNAs were enriched in the regulatory pathways of cell proliferation. Fascinatingly, among these down-regulated mRNAs, Ccna2 stood out as a common target of several p53 responsive miRNAs (miR-124 and miR-29), which functioned as the antagonist of p21 in cell cycle regulation. Silencing of Ccna2 remarkably triggered the cellular senescence, while Ccna2 overexpression delayed cellular senescence and significantly reversed the senescence-induction effect of miR-124 and miR-29. Moreover, these p53 responsive miRNAs were significantly up-regulated during the senescence process of p21-deficient cells; overexpression of p53 responsive miRNAs or knockdown of Ccna2 evidently accelerated the cellular senescence in the absence of p21. Taken together, our data suggested that the p53/miRNAs/Ccna2 pathway might serve as a novel senescence modulator independent of p53/p21 pathway.

Indexed as

Cellular SenescenceAnimalsCells, CulturedCyclin A2Cyclin-Dependent Kinase Inhibitor p21HumansMaleMiceMice, Inbred C57BLMicroRNAsNIH 3T3 CellsTumor Suppressor Protein p53CCNA2 protein, mouseCyclin A2Cyclin-Dependent Kinase Inhibitor p21MicroRNAsTumor Suppressor Protein p53agingCcna2cellular senescencemiRNAp53

Identifiers

PMID30848072
PMCPMC6516184
OpenAlexW2921157237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.